Vimarsana
Biggest News Aggregation in the World

Page 7 - Scale Speedometer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scale Speedometer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scale Speedometer Today - Breaking & Trending Today

Covid-19 vaccination: Can India deliver that shot to all? - Vimarsana News

Covid-19 vaccination: Can India deliver that shot to all?

Covid-19 vaccination: Can India deliver that shot to all?   Fri, Dec 18 2020 07:37:33 PM New Delhi, Dec 18 (IANS): As the wealthy nations like the US and the UK begin vaccinating their public, the road ahead for India does not look very rosy as both Pfizer-BioNTech and Moderna vaccines currently making headlines are yet to reach the country owing to a host of factors including scarce supply, tricky transport and an absence of proper cold chain. For over 130 crore Indians, two promising vaccines -- Astrazeneca and Oxford university developed and Serum Institute of India (SII)-manufactured Co...

Covid-19 vaccination: Can India deliver that shot to all? - www.indianweekender.co.nz - Vimarsana News

Covid-19 vaccination: Can India deliver that shot to all? - www.indianweekender.co.nz

Covid-19 vaccination: Can India deliver that shot to all? Covid-19 vaccination: Can India deliver that shot to all? Saturday, December 19, 2020 IWK Bureau As the wealthy nations like the US and the UK begin vaccinating their public, the road ahead for India does not look very rosy as both Pfizer-BioNTech and Moderna vaccines currently making headlines are yet to reach the country owing to a host of factors including scarce supply, tricky transport and an absence of proper cold chain. For over 130 crore Indians, two promising vaccines -- Astrazeneca and Oxford university develo...

Coronavirus vaccine deals: India, Oxford numbers see dip, but still on top; Pfizer gains most - Vimarsana News

Coronavirus vaccine deals: India, Oxford numbers see dip, but still on top; Pfizer gains most

Synopsis Analysis of contracts countries are signing with vaccine makers for advance booking of candidates shows that the deals are still fluid, changing in a matter of days with some companies gaining and some losing orders given that most candidates are still in trial stage. (This story originally appeared in on Dec 14, 2020)BENGALURU: Overall global orders to secure vaccines shrunk 19.2 million doses to touch 7.1 billion as of December 11, compared to 7.12 billion as of November 30. India, which had deals for 1.6 billion doses by the end of last month has 1.5 billion as per data from Duk...

Explained: India's preparedness and Covid-19 vaccines - Vimarsana News

Explained: India's preparedness and Covid-19 vaccines

December 14, 2020 Haryana’s health minister Anil Vij announced that he tested positive for the Covid-19, leading many to draw connections with his participation in the trials of one of the vaccine candidates. The immediate media coverage and the social media conversations that followed conflated Vij’s diagnosis with the trial in a way suggested that the inoculation of Covaxin from Bharat Biotech may be ineffective. In reality, it is not known whether the minister was given a placebo or the actual inoculation. Even if he did get a shot of Covaxin, it is not meant to be protective ...

Vaccine deals: India, Oxford numbers see dip, but still on top; Pfizer gains most | India News - Vimarsana News

Vaccine deals: India, Oxford numbers see dip, but still on top; Pfizer gains most | India News

BENGALURU: Overall global orders to secure vaccines shrunk 19.2 million doses to touch 7.1 billion as of December 11, compared to 7.12 billion as of November 30. India, which had deals for 1.6 billion doses by the end of last month has 1.5 billion as per data from Duke University’s Launch & Scale Speedometer, which is tracking global vaccine deals daily. Analysis of contracts countries are signing with vaccine makers for advance booking of candidates shows that the deals are still fluid, changing in a matter of days with some companies gaining and some losing orders given that most candida...